VBLT - Vascular Biogenics Ltd
Close
0.171
-0.022 -12.690%
Share volume: 2,009,570
Last Updated: Fri 13 Oct 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.19
-0.02
-11.26%
Summary score
8%
Profitability
0%
Dept financing
6%
Liquidity
34%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.67%
Return on assets
-9.46%
Return on sales
-3576.24%
Return on invested capital
-341.07%
Total debt ratio
16.21%
Debt ratio change over timeo
-1.06%
Current Ratio
7.91%
Quick Ratio
0%
Cash Position Ratio
2.91%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.63%
Return on assets
-12.1%
Return on sales
-4354.03%
Return on invested capital
-200.91%
Total debt ratio
23.77%
Debt ratio change over timeo
-1.14%
Current Ratio
5.09%
Quick Ratio
0%
Cash Position Ratio
2.04%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.72%
Return on assets
-11.97%
Return on sales
-3991.77%
Return on invested capital
-177.39%
Total debt ratio
19.24%
Debt ratio change over time
-1.09%
Current Ratio
6.41%
Quick Ratio
0%
Cash Position Ratio
2.53%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.24%
Return on assets
-98.35%
Return on sales
2343.92%
Return on invested capital
-22.66%
Total debt ratio
-105.83%
Debt ratio change over time
-1.06%
Current Ratio
-2.67%
Quick Ratio
0%
Cash Position Ratio
-1.61%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VBLT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -10.67% | 0% | 0% | 29.06% |
| Return on assets | -9.46% | 0% | 0% | -9.75% |
| Return on sales | -3576.24% | 0% | 0% | -1469.44% |
| Return on invested capital | -341.07% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 16.21% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.06% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 5.09% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.04% | 0% | 0% | 5.68% |
| Liquididy | 44% | 0% | 0% | 62% |
| Short-term ratios | VBLT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -14.63% | 0% | 0% | -16.12% |
| Return on assets | -12.1% | 0% | 0% | -14.95% |
| Return on sales | -4354.03% | 0% | 0% | -3498.94% |
| Return on invested capital | -200.91% | 0% | 0% | 96.56% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 23.77% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.14% | 0% | 0% | 0.09% |
| Dept financing | 7% | 0% | 0% | 50% |
| Current Ratio | 5.09% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.04% | 0% | 0% | 5.68% |
| Liquididy | 31% | 0% | 0% | 75% |